Polymorphism in the fractalkine receptor CX3CR1 as a genetic risk factor for coronary artery disease

Abstract

Coronary atherosclerosis is a major cause of death in industrialized countries. Monocytes, which play a key role in atherosclerosis, migrate into the vessel wall, presumably guided by specific chemoattractant and adhesion molecules. A compelling candidate for this role is the chemokine receptor CX3CR1, which is expressed on monocytes and acts as either a chemotactic receptor or an adhesion molecule, depending on whether its ligand, fractalkine, is presented free or membrane bound. A common variant of CX3CR1 was recently identified, encoded by the alleles 1249 and M280, which form a common l249M280 haplotype. When CX3CR1 geno-types were analyzed in 151 patients with acute coronary syndromes and in 249 healthy controls, CX3CR1 1249 heterozygosity was associated with a markedly reduced risk of acute coronary events, independent of established acquired coronary risk factors (eg, smoking, diabetes). The adjusted odds ratio for this allele was 0.43 (95% confidence interval, 0.26-0.72; P = .001). Consistent with this, functional analysis of peripheral blood mononuclear cells showed that CX3CR1 1249 heterozygosity was associated with a significant decrease in the number of fractalkine binding sites per cell. The results show that CX3CR1 1249 is an independent genetic risk factor for coronary artery disease and that CX3CR1 may be involved in the pathogenesis of atherosclerotic disease. ¢ 2001 by The American Society of Hematology.